Company Overview and News

 
Petrol prices hit record levels on the road to $2.30 a litre

2018-05-21 nzherald.co.nz
A petrol retailer claims little more can be done to make petrol cheaper at the pump. Prices in some parts of the country are at their highest levels at just under $2.30 a litre for 91 octane.

 
Shares gain as Ryman posts record profit

2018-05-18 nzherald.co.nz
New Zealand shares rose as Goodman Property Trust's joint venture with GIC sold seven buildings in downtown Auckland, and as Ryman Healthcare chalked up another record profit. A2 Milk Co and Comvita fell.

 
Stock Takes: A2 fall shows NZ's frailty

2018-05-17 nzherald.co.nz
A2 Milk's plunge on Wednesday shows just how exposed the New Zealand market can be to one stock.

 
Supermarket chain Foodstuffs admits facial recognition technology used in some stores

2018-05-13 nzherald.co.nz
New Zealand's largest supermarket company has quietly rolled out facial recognition CCTV technology in some of its North Island stores.

 
Comment: Super Fund should not be Auckland's cash cow

2018-05-09 nzherald.co.nz
Is an unexpected white knight riding into Auckland, weaving through the chronic congestion of a city bursting at the seams?

 
MARKET WRAP: NZ shares rise, Xero flies

2018-05-07 nbr.co.nz
Harbour Asset Management analyst Shane Solly says Westpac is still under pressure following the Royal Commission’s findings.

 
NZ shares mixed, A2 gains while Gentrack, Spark, bank stocks drop

2018-05-04 nzherald.co.nz
New Zealand shares were mixed, with A2 Milk pulling the index up while Gentrack Group, Spark New Zealand and banking stocks dropped.

 
NZ shares rise, Z Energy gains after annual earnings

2018-05-03 nzherald.co.nz
New Zealand shares gained, led by Z Energy following its annual results, with Chorus and Genesis also rising.

 
Z Energy thinks watchdog review would show competitive petrol pricing

2018-05-03 nbr.co.nz
Credit card details are required to authenticate your account. You won't be charged until your trial has ended. Cancel anytime.

 
Z Energy lifts annual net profit 8% on extra Caltex contribution

2018-05-02 nbr.co.nz
Z Energy’s net profit rose 8%, although its preferred replacement cost result was up 16%, reflecting an extra two-month contribution from the Caltex business and an 18% jump in crude oil prices.

 
Z Energy's profit rises

2018-05-02 radionz.co.nz
The country's biggest fuel company, Z Energy, has reported a modest lift in its profit as competition and supply disruption partly offset increased sales and higher margins.

 
Z Energy $263 million profit a record for fuel retailer

2018-05-02 nzherald.co.nz
Z Energy, the nation's biggest fuel retailer, has announced a $263 million profit for the 12 months ended March 31, 2018.

 
NZ shares dip; Kiwi Property, Fletcher drop

2018-05-01 nzherald.co.nz
New Zealand shares fell slightly, despite a gain in energy stocks and ANZ Bank New Zealand rising on its first-half earnings.

 
NZ shares mixed ahead of Anzac Day holiday; A2, Synlait fall

2018-04-24 nzherald.co.nz
New Zealand shares were mixed in light trading ahead of tomorrow's public holiday, with A2 Milk Co and Synlait Milk continuing to weaken while Fisher and Paykel Healthcare Corp rebounded and Fletcher Building extended gains.

 
Shares fall as investors weight up Fletcher rights issue

2018-04-17 nzherald.co.nz
New Zealand shares fell as investors weighed up the impact of Fletcher Building's deeply discounted rights issue soaking up demand from the broader market. Auckland International Airport and exporters A2 Milk Co and Comvita dropped.

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

2018-05-21 - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...